Dr Adrian Selim is a haematologist with extensive expertise in malignant haematology. In 2009 Dr Selim completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Bond University and subsequently undertook haematology training in Sydney’s Eastern hospital network. He completed a bone marrow transplant fellowship at the Bristol Royal Infirmary, United Kingdom and in 2019 became the inaugural cell therapies fellow at Peter MacCallum Cancer Centre. During this fellowship he gained extensive experience in novel immunotherapies, particularly chimeric antigen receptor T-cell therapy (CAR-T), as well as a strong clinical research foundation.
Dr Selim has authored numerous peer-reviewed publications. He is a fellow of both the Royal Australasian College of Physicians (FRACP) and the Royal College of Pathologists of Australasia (FRCPA). His clinical experience covers a wide range of malignant and non-malignant blood disorders including acute and chronic leukaemias, lymphoma, myeloma, myeloproliferative disorders and myelodysplastic syndromes.
Affiliations & Memberships
- European Haematology Association (EHA)
- Australasian Lymphoma and Leukaemia Group (ALLG)
- eviQ Cellular Therapies Reference Committee
- Royal Australasian College of Physicians (RACP)
- Royal College of Pathologist of Australasia (RCPA)
Languages spoken
Special Interests
Dr Adrian Selim accepts referrals for malignant and non-malignant blood disorders, with a special clinical interest in:
- Leukaemia
- Lymphoma
- Multiple myeloma
- Myelodysplasia
- Myeloproliferative neoplasms